Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Br J Haematol. 2008 Mar 27;141(5):615–621. doi: 10.1111/j.1365-2141.2008.07086.x

Table I.

Demographic and Clinical characteristics of participants

Characteristic All CLL patients
(N=1,750)
N (%)
Bone Marrow
Failure (N = 228)
N (%)
AID Patients
(N=75)
N (%)
Age at CLL diagnosis (years)
median (range)
63.7 (17.3–94.7) 63.3 (32.4–94.5) 66.7 (30.0–85.0)
Gender
   Male 1198 (68%) 160 (70%) 62 (83%)
   Female 552 (32%) 68 (30%) 13 (17%)
Clinical stage at diagnosis of
CLL (Rai)*
   0 1010 (59%) 74 (33%) 26 (35%)
   I 484 (28%) 35 (15%) 24 (32%)
   II 119 (7%) 22 (10%) 11 (15%)
   III 46 (3%) 40 (18%) 6 (8%)
   IV 65 (4%) 57 (25%) 8 (11%)
Unknown 26
FISH
   Normal, 13q, trisomy 12 379 (66%) 42 (48%) 15 (56%)
   17p-, 11q- 198 (34%) 45 (52%) 12 (44%)
   Missing 1173 141 48
Unmutated IgVH
   No 261 (58%) 23 (33%) 7 (35%)
   Yes 189 (42%) 46 (67%) 13 (65%)
   Missing 1300 159 55
ZAP 70
   Negative 187 (58%) 15 (37%) 1 (20%)
   Positive (≥20%) 135 (42%) 26 (63%) 4 (80%)
   Missing 1428 187 70
CD38
   Negative 393 (69%) 47 (58%) 22 (56%)
   Positive (≥30%) 176 (31%) 34 (42%) 17 (44%)
   Missing 1181 147 36
Local Patient+
   No 1437 (82%) 196 (86%) 43 (57%)
   Yes 313 (18%) 32 (14%) 32 (43%)
*

Patients were staged using standard criteria which did not distinguish between cytopenia caused by bone marrow failure vs. AID

+

Patients were considered to be non-referred (local) if they lived within 120 miles of Mayo Clinic Rochester excluding the Minneapolis – St. Paul metropolitan area.